Dipole Density Mapping of Right and Left Atrial Supraventricular Tachycardia

Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01914575

Acronym

DDRAMATIC-SVT

Enrollment

Registered

2013-08-02

Start date

2014-01-22

Completion date

2016-05-16

Last updated

2019-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraventricular Tachycardia

Brief summary

Use of dipole density mapping to identify activation in complex supraventricular tachycardias

Interventions

DEVICEMapping with the Acutus Medical System followed by Ablation

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

1. aged 18 to 75 years 2. scheduled for ablation of atypical atrial flutter or paroxysmal atrial fibrillation 3. able and willing to give informed consent

Exclusion criteria

1. implanted prosthetic, artificial, or repaired cardiac valves in the chamber being mapped, permanent pacemaker or ICD leads in the chamber being mapped, and/or hypercoagulopathy or an inability to tolerate anticoagulation . 2. myocardial infarction within the prior two months 3. cardiac surgery within the prior three months 4. intracardiac thrombus 5. clinically significant tricuspid valve regurgitation or stenosis 6. any cerebral ischemic event in the prior six months 7. pregnant or nursing 8. currently enrolled in any other clinical investigation

Design outcomes

Primary

Measure	Time frame
The number of patients with device-related complications	7 days
The number of patients for which activation maps can be created	7 days

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026